Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   familial partial lipodystrophy
  

Disease ID 530
Disease familial partial lipodystrophy
Definition
Inherited conditions characterized by the partial loss of ADIPOSE TISSUE, either confined to the extremities with normal or increased fat deposits on the face, neck and trunk (type 1), or confined to the loss of SUBCUTANEOUS FAT from the limbs and trunk (type 2). Type 3 is associated with mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
Synonym
familial lipodystrophy of limbs and trunk
familial lipodystrophy of limbs and/or trunk
familial partial lipodystrophies
familial partial lipodystrophy (disorder)
kobberling-dunnigan syndrome
koberling dunnigan syndrome
koberling-dunnigan syndrome
lipodystrophies, familial partial
lipodystrophy, familial partial
lipodystrophy, familial partial [disease/finding]
partial lipodystrophies, familial
partial lipodystrophy, familial
Orphanet
DOID
UMLS
C0271694
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:1)
C0004153  |  atherosclerosis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:5)
5468  |  PPARG  |  CTD_human
857  |  CAV1  |  CTD_human
4000  |  LMNA  |  CTD_human
5506  |  PPP1R3A  |  CTD_human
208  |  AKT2  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:5)
4000  |  LMNA  |  CIPHER;CTD_human
208  |  AKT2  |  CTD_human
857  |  CAV1  |  CTD_human
5506  |  PPP1R3A  |  CTD_human
5468  |  PPARG  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:32)
51099  |  ABHD5  |  1.572  |  DISEASES
10555  |  AGPAT2  |  4.731  |  DISEASES
208  |  AKT2  |  2.942  |  DISEASES
270  |  AMPD1  |  2.775  |  DISEASES
27329  |  ANGPTL3  |  1.698  |  DISEASES
26580  |  BSCL2  |  4.527  |  DISEASES
11132  |  CAPN10  |  1.144  |  DISEASES
825  |  CAPN3  |  1.175  |  DISEASES
857  |  CAV1  |  2.443  |  DISEASES
63924  |  CIDEC  |  4.055  |  DISEASES
1382  |  CRABP2  |  1.522  |  DISEASES
1734  |  DIO2  |  1.375  |  DISEASES
1735  |  DIO3  |  1.894  |  DISEASES
196385  |  DNAH10  |  3.826  |  DISEASES
2010  |  EMD  |  5.127  |  DISEASES
5167  |  ENPP1  |  1.06  |  DISEASES
8087  |  FXR1  |  1.842  |  DISEASES
23463  |  ICMT  |  1.988  |  DISEASES
84456  |  L3MBTL3  |  3.061  |  DISEASES
4000  |  LMNA  |  7.704  |  DISEASES
84823  |  LMNB2  |  4.126  |  DISEASES
57591  |  MKL1  |  1.387  |  DISEASES
7101  |  NR2E1  |  2.504  |  DISEASES
5498  |  PPOX  |  1.486  |  DISEASES
5696  |  PSMB8  |  2.253  |  DISEASES
284119  |  PTRF  |  2.75  |  DISEASES
6258  |  RXRG  |  2.105  |  DISEASES
6720  |  SREBF1  |  2.912  |  DISEASES
7341  |  SUMO1  |  1.15  |  DISEASES
7068  |  THRB  |  1.915  |  DISEASES
10587  |  TXNRD2  |  1.257  |  DISEASES
10269  |  ZMPSTE24  |  4.62  |  DISEASES
Locus(Waiting for update.)
Disease ID 530
Disease familial partial lipodystrophy
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:2)
Disease ID 530
Disease familial partial lipodystrophy
Manually Symptom
UMLS  | Name(Total Manually Symptoms:3)
C0524620  |  insulin resistance syndrome
C0520679  |  obstructive sleep apnea
C0011860  |  diabetes
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:21)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11575937145974144000LMNAumls:C0271694BeFreeFailure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.0.1574326912003LMNA1156136985GA,T
rs11575937145974142010EMDumls:C0271694BeFreeFailure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.0.0002714422003LMNA1156136985GA,T
rs11575937105875854000LMNAumls:C0271694BeFreeNuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.0.1574326912000LMNA1156136985GA,T
rs11575937233132864000LMNAumls:C0271694BeFreeWe describe the first cases of AR-EDMD and autosomal dominant familial partial lipodystrophy (FPLD) in the Hutterite population resulting from homozygous or heterozygous R482Q mutations in the lamin A/C gene (LMNA).0.1574326912013LMNA1156136985GA,T
rs11575937187281244000LMNAumls:C0271694BeFreeBoth sisters were found to be heterozygous for the R482Q mutation in the lamin A/C gene (LMNA) gene, establishing the definitive diagnosis as Dunnigan-type familial partial lipodystrophy complicated by severe insulin resistance and secondary PCOS.0.1574326912008LMNA1156136985GA,T
rs267607545157489024000LMNAumls:C0271694BeFreeIn search of a structural cause for the variety of inherited diseases caused by A-type lamin mutations, we have studied the molecular organization of GFP-tagged lamin A and lamin C mutants R453W and R386K, found in Emery-Dreifuss muscular dystrophy (EDMD), and lamin A and lamin C mutant R482W, found in patients with Dunnigan-type familial partial lipodystrophy (FPLD).0.1574326912005LMNA1156136121GA,T
rs28928902180417754000LMNAumls:C0271694BeFreeThe heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy.0.1574326912007LMNA1156136951CG,T
rs57747780115258834000LMNAumls:C0271694BeFreeGene analysis of the proband revealed Tyr481His mutation in the exon 8 of lamin A/C (LMNA) gene which is adjacent to the codon mutated in reported cases of familial partial lipodystrophy.0.1574326912001LMNA1156136981TC
rs57830985110784664000LMNAumls:C0271694BeFreeAlthough FPLD mutations are predominantly localized in exon 8 of LMNA, the finding of a novel mutation at codon 584, together with the R582H heterozygous substitution recently described, confirms that the C-terminal region specific to the lamin A isoform is a second susceptibility region for mutations in FPLD.0.1574326912000LMNA1156138534GA
rs57920071219932184000LMNAumls:C0271694BeFreeIn addition, the tail regions of A-type lamin variants that occur in Dunnigan-type familial partial lipodystrophy of (R482W) and Hutchison Gilford progeria syndrome (∆607-656) bind to the SREBP1 polypeptide in vitro, and the corresponding FLAG-tagged full-length lamin variants co-immunoprecipitate the SREBP1 polypeptide in cells.0.1574326912011LMNA1156136984CT
rs57920071255247054000LMNAumls:C0271694BeFreeDunnigan type familial partial lipodystrophy (FPLD2; OMIM
151660) is caused in most cases by the A-type lamin R482W mutation.0.1574326912016LMNA1156136984CT
rs57920071219932186720SREBF1umls:C0271694BeFreeIn addition, the tail regions of A-type lamin variants that occur in Dunnigan-type familial partial lipodystrophy of (R482W) and Hutchison Gilford progeria syndrome (∆607-656) bind to the SREBP1 polypeptide in vitro, and the corresponding FLAG-tagged full-length lamin variants co-immunoprecipitate the SREBP1 polypeptide in cells.0.0008143262011LMNA1156136984CT
rs57920071126692684000LMNAumls:C0271694BeFreePhenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation.0.1574326912003LMNA1156136984CT
rs57920071117928104000LMNAumls:C0271694BeFreeBy contrast, lamin A and C molecules harboring a point mutation (R482W), which gives rise to a dominant form of familial partial lipodystrophy, behave in a manner that is indistinguishable from wild-type lamins A and C, at least with respect to targeting and assembly within the nuclear lamina.0.1574326912001LMNA1156136984CT
rs57920071157489024000LMNAumls:C0271694BeFreeIn search of a structural cause for the variety of inherited diseases caused by A-type lamin mutations, we have studied the molecular organization of GFP-tagged lamin A and lamin C mutants R453W and R386K, found in Emery-Dreifuss muscular dystrophy (EDMD), and lamin A and lamin C mutant R482W, found in patients with Dunnigan-type familial partial lipodystrophy (FPLD).0.1574326912005LMNA1156136984CT
rs57920071195746354000LMNAumls:C0271694BeFreeStructure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD).0.1574326912009LMNA1156136984CT
rs57920071128323184000LMNAumls:C0271694BeFreeTwenty-six subjects (9.7%) were positive for a beta-cell antibody, one subject had familial partial lipodystrophy and the lamin A/C mutation R482W, and two subjects had the mitochondrial mutation A3243G.0.1574326912003LMNA1156136984CT
rs58932704157489024000LMNAumls:C0271694BeFreeIn search of a structural cause for the variety of inherited diseases caused by A-type lamin mutations, we have studied the molecular organization of GFP-tagged lamin A and lamin C mutants R453W and R386K, found in Emery-Dreifuss muscular dystrophy (EDMD), and lamin A and lamin C mutant R482W, found in patients with Dunnigan-type familial partial lipodystrophy (FPLD).0.1574326912005LMNA1156136413CT
rs72551363250049735468PPARGumls:C0271694BeFreeStructural basis of the transactivation deficiency of the human PPARγ F360L mutant associated with familial partial lipodystrophy.0.127067422014PPARG312417048TA
rs72551363124539195468PPARGumls:C0271694BeFreePPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.0.127067422002PPARG312417048TA
rs72551364173122725468PPARGumls:C0271694BeFreeImpaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.0.127067422007PPARG312433900CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 530
Disease familial partial lipodystrophy
Case(Waiting for update.)